A retrospective chart review and thematic analysis of patients seeking mpox vaccination during the initial outbreak in 2022–2023: evaluation of access, motivations, and stigma
Abstract Background Mpox was identified in many previously non-endemic countries, including Canada, as of May 2022. In response to the increase in cases in Canada, and more specifically the province of Ontario, the vaccine Imvamune was rolled out. Eligibility was governed by provincial health author...
Saved in:
| Main Authors: | Kody Muncaster, Chelsea Masterman, Tamara Barnett, Robert A. Kozak, Erin Mandel, Karen Campbell, Mia J. Biondi MJ |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | BMC Public Health |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12889-024-20948-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emergence of Mpox and new epidemics: psychological and social impact of stigma in communication and prevention
by: Giacomo Fiacco, et al.
Published: (2025-01-01) -
Mpox Vaccine Hesitancy Among Brazilian Men Who Have Sex with Men: A National Cross-Sectional Study
by: Guilherme Reis de Santana Santos, et al.
Published: (2024-10-01) -
Possible scenarios for the spread of mpox outside the endemic focus in Africa
by: Eskild Petersen, et al.
Published: (2025-04-01) -
Challenges and Ongoing Actions to Address the Mpox Emergency in Africa
by: Faraan O. Rahim, et al.
Published: (2024-11-01) -
Understanding mpox - A resurgent global health challenge
by: Supriya Satish Patil
Published: (2024-07-01)